Prevention trials in Alzheimer disease: One step forward?

Neurology

Volumn 67, Issue 9 SUPPL. 3, 2006, Pages

  Touchon, J ^a,b   Portet, F ^a,b   Gauthier, S ^c  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b INSERM   (France)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GINKGO BILOBA EXTRACT;

ALZHEIMER DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; HUMAN; MEDICAL ETHICS; METHODOLOGY; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY;

EID: 33750599512     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.67.9_suppl_3.s21     Document Type: Short Survey

References (12)

1. Ferri CP, Prince M, Brayne C, et al. Alzheimer Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-2117.
2. Morris JC. Dementia update 2003. Alzheimer Dis Assoc Disord 2003;17:245-258.
3. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Kokmen E, Tangelos EG. Aging, memory, and mild cognitive impairment. Int Psychogeriatr 1997;9:65-69.
4. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-246.
5. Ritchie K, Touchon J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet 2000;355:225-228.
6. Gauthier S, Touchon J. Mild cognitive impairment is not a clinical entity and should not be treated. Arch Neurol 2005;62:1164-1166.
7. Visser PJ, Scheltens P, Verhey FR. Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer disease? J Neurol Neurosurg Psychiatry 2005;76:1348-1354.
8. Gagnon M, Dartigues JF, Mazaux JM, Dequae L, Letenneur L, Giroire JM, et al. Self-reported memory complaints and memory performance in elderly French community residents: results of the PAQUID Research Program. Neuroepidemiology 1994;13:145-154.
9. Green RC, Cupples LA, Go R, et al. Risk of dementia among White and African American relatives of Alzheimer disease patients. JAMA 2002;287:329-336.
10. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 1997;278:1349-1356.
11. Portet F, Ousset PJ, Visser PJ, et al. Mild cognitive impairment in medical practice: critical review of the concept and new diagnostic procedure. Report of the MCI working group of the European Consortium on Alzheimer disease (EADC). J Neurol neurosurg psychiatry 2006;77:714-718.
12. DeKosky ST, Fitzpatrick A, Ives DG. Ginkgo Evaluation of Memory (GEM) Study: Design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemp Clin Trials 2006;27:238-253.